BUZZ - Zoetis shares rise as quarterly results beat expectations and guidance is raised

November 5 - ** Animal healthcare company Zoetis (ZTS.N) shares rose 2.2% in pre-market trading to $92.21

** ZTS raised its adjusted earnings per share guidance for fiscal 2026 from the previous $6.19–$6.28 to $6.25–$6.35

** Chief Executive Officer Kristin Peck stated that ongoing pressure in the companion animal business was partly offset by growth in the livestock and diagnostics segments

** Third quarter revenue was $2.39 billion, surpassing analysts’ average estimate of $2.30 billion — LSEG data

** Adjusted quarterly earnings per share were $1.75, above the expected $1.51

** Chief Medical Officer Richard Goldstein said that pet lifespans have increased by about 1.5 to 1.7 times compared to forty years ago, driving demand for treatment of chronic and geriatric diseases (link)

** Of 18 analysts, 12 gave a “hold” rating and 6 issued a “buy” rating, with a median price target of $85 — LSEG

** As of the previous trading session’s close, the stock was down 29% year-to-date

(To assist non-English speakers, Reuters offers its reports automatically translated into several other languages. Because automated translation may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of the automated translation and provides it solely for reader convenience. Reuters accepts no responsibility for any damage or loss arising from use of the automated translation feature.)